Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...
Novartis plans to acquire Avidity Biosciences to add RNA therapeutics to its neuroscience biz to target rare genetic ...
Learn more about whether AbbVie Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Sudo Biosciences, ("Sudo"), a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced positive topline results from ...
Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.
The Swiss drugmaker on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash ...
WARREN, ID / ACCESS Newswire / October 28, 2025 / Sidney Resources Corp. (OTCID:SDRC) ("Sidney" or the "Company") is pleased to announce a major advancement at its flagship Warren District Project in ...
To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programs To bring deep ...
Logicalis, a leading global technology service provider, has announced significant progress in its FY25 Responsible Business Report, demonstrating measurable impact through strategic environmental, ...
Novartis has agreed to acquire Avidity Biosciences Inc., a San Diego-based, biopharmaceutical company focused on a new class of therapeutics enabling RNA delivery to muscle. The acquisition will ...
Advantech Unveils Edge AI Solutions Accelerated by NVIDIA Jetson Thor for Robotics, Medical AI, and Data Intelligence IRVINE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback